Genomics and Cancer Epigenetics

Genomics and Cancer Epigenetics focus on understanding the genetic and epigenetic changes that drive cancer development and progression. Genomics refers to the study of an organism's complete set of DNA, including all its genes. In cancer, genomic research seeks to identify mutations, genetic alterations, and abnormal gene expressions that contribute to tumor growth, helping to develop targeted therapies. Cancer epigenetics examines changes in gene expression that are not caused by alterations in the DNA sequence itself, but by other mechanisms such as DNA methylation, histone modification, or non-coding RNA activity. These epigenetic changes can activate oncogenes or silence tumor suppressor genes, contributing to cancer. Understanding both genomic and epigenetic factors is crucial for developing personalized cancer treatments and predicting patient outcomes.

    Related Conference of Genomics and Cancer Epigenetics

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    Genomics and Cancer Epigenetics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in